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Measurement Properties of Tools Used to Assess Depression in Adults
With and Without Autism Spectrum Conditions: A Systematic Review
S. A. Cassidy , L. Bradley, E. Bowen, S. Wigham, and J. Rodgers
Depression is the most commonly experienced mental health condition in adults with autism spectrum conditions
(ASC). However, it is unclear what tools are currently being used to assess depression in ASC, or whether tools need to
be adapted for this group. This systematic review therefore aimed to identify tools used to assess depression in adults
with and without ASC, and then evaluate these tools for their appropriateness and measurement properties. Medline,
PsychINFO and Web of Knowledge were searched for studies of depression in: (a) adults with ASC, without co-morbid
intellectual disability; and (b) adults from the general population without co-morbid conditions. Articles examining the
measurement properties of these tools were then searched for using a methodological filter in PubMed, and the quality
of the evidence was evaluated using the COSMIN checklist. Twelve articles were identified which utilized three tools to
assess depression in adults with ASC, but only one article which assessed the measurement properties of one of these
tools was identified and thus evaluated. Sixty-four articles were identified which utilized five tools to assess depression
in general population adults, and fourteen articles had assessed the measurement properties of these tools. Overall, two
tools were found to be robust in their measurement properties in the general population—the Beck Depression Inven-
tory (BDI-II), and the patient health questionnaire (PHQ-9). Crucially only one study was identified from the COSMIN
search, which showed weak evidence in support of the measurement properties of the BDI-II in an ASC sample. Impli-
cations for effective measurement of depression in ASC are discussed. Autism Res 2018, 0: 000–000. VC 2018 The
Authors Autism Research published by International Society for Autism Research and Wiley Periodicals, Inc.
Lay Summary: Depression is the most common mental health problem experienced by adults with autism. How-
ever, the current study found very limited evidence regarding how useful tools developed for the general population
are for adults with autism. We therefore suggest how these tools could be adapted to more effectively assess depres-
sion in adults with autism, and improve these individuals access to mental health assessment and support.
Keywords: autism spectrum condition; general population; Asperger syndrome; depression; measurement properties;
assessment; systematic review; COSMIN
Introduction
Recent research has shown that a majority of adults
with an autism spectrum condition (ASC) meet diag-
nostic criteria for at least one psychiatric condition
(79%), with depression being the most common [Lever
& Geurts, 2016]. Studies have also highlighted high
rates of depression in adults with ASC [e.g., Cassidy
et al., 2014; Hofvander et al., 2009]. Depression is also
the most common first concern prior to adults obtain-
ing an ASC diagnosis [Jones, Goddard, Hill, Henry, &
Crane, 2014]. Adults with ASC, without co-morbid
intellectual disability (the focus of this review), who
have greater insight into their own difficulties, are also
more likely to experience depression than those with
less insight [Gotham, Bishop, Brunwasser, & Lord,
2014]. The consequences of not detecting depression in
those with ASC can be devastating. Depression has
been shown to increase risk of adults with ASC contem-
plating, planning [Cassidy et al., 2014], or dying by sui-
cide [Hirvikoski et al., 2016]. Clearly, it is crucial to
effectively identify depression in this group. However,
it is unclear if there are valid tools available to assess
depression in those with ASC.
ASC is characterized by difficulties in socialization,
imagination, communication, narrow obsessive inter-
ests, and sensory difficulties [APA, 2013]. A number of
depressive symptoms may overlap with symptoms and
behaviors in ASC, such as social withdrawal, difficulties
with sleep, flat affect, and reduced eye contact [Stewart,
Barnard, & Pearson, 2006], resulting in diagnostic over-
shadowing. This overlap of symptoms could present
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challenges for clinicians in the identification of depres-
sion in ASC, particularly when using tools developed
for those without ASC. For example, individuals with
ASC could score higher on traditional depression mea-
sures, by endorsing items which may be capturing their
ASC symptoms as opposed to depression per se. This
could mean that depression symptoms are over-
endorsed using these measures, even in the absence of
depression, in those with ASC compared to those with-
out ASC. Equally, lack of autism-specific items tailored
to the unique presentation of depression in ASC, such
as loss of absorption in a special interest [Clarke, Little-
johns, Corbett, & Joseph, 1989; Gillberg, 1985], agita-
tion, change in sleep pattern or social withdrawal
[Ghaziuddin, 2005], could potentially underestimate
depression in this group. Either way, there are reasons
to suspect that traditional measures of depression may
not adequately capture the unique presentation of
depression in those with ASC, and therefore increase
the risk of inaccurate identification of depression in
these individuals.
In addition to the overlap of symptoms between ASC
and depression, there are cognitive characteristics of
ASC which could affect the diagnostic accuracy of exist-
ing depression measures in this group. For example,
many depression measures rely on self-report, and the
ability to reflect and report on one’s internal emotional
experience. Difficulties articulating one’s own internal
emotional experience (termed Alexithymia) is common
in those with ASC [e.g., Bird et al., 2010]. Literal inter-
pretation of questions [Happe, 1995] could also impede
ability to correctly interpret questions such as “I could
not shake off the blues” [item 2 of the Centre for Epide-
miological Studies Depression Scale—Revised; Eaton,
Smith, Ybarra, Muntaner, & Tien, 2004]. Therefore, the
mode of assessment and language used could affect the
content validity of traditional depression measures in
those with ASC.
Given the potentially tragic consequences of failing
to accurately identify depression in adults with ASC, it
is extremely important for clinicians, researchers and
service providers to have access to appropriate tools to
effectively assess depression in these individuals. How-
ever, it is unknown which tools to assess depression
have been used in those with ASC, what the evidence is
regarding the appropriateness and measurement proper-
ties of these tools, or whether existing tools used in the
general population need to be adapted for those with
ASC. To address this knowledge gap, we conducted a
comprehensive two-stage systematic review of the avail-
able evidence. First, we searched the literature for all
available studies which have utilized a tool to assess
depression frequently (at least twice), with evidence of
validity (i.e., with reference to a published study), in;
(a) adults with ASC, without co-morbid intellectual
disability; and (b) adults from the general population,
without co-morbid conditions.
To guarantee appropriate conclusions regarding the
appropriateness and measurement properties of an
instrument, it is crucial to ascertain whether studies are
of high methodological quality. To accomplish this, a
checklist was developed in a multi-disciplinary, interna-
tional consensus-study involving 43 experts in health
outcome measurement: The consensus based standards
for the selection of health measurement instruments
(COSMIN). A growing number of studies are using COS-
MIN to assess the evidence for the appropriateness and
measurement properties of tools in ASC [Hanratty
et al., 2015; Wigham & McConachie, 2014], in order to
make evidence based recommendations for future
research and clinical practice. Hence, we searched for
evidence regarding the measurement properties of these
tools in each group, using a comprehensive search tool
validated for this purpose [Mokkink et al., 2010;
Terwee, Jansma, Riphagen, & de Vet, 2009], and subse-
quently rated the quality of the available evidence
using this validated research tool [COSMIN, Mokkink,
Terwee, Patrick, Alonso, & Stratford, 2012]. Including
searches looking at both adults with and without ASC
enables us to draw comparisons in the state of the evi-
dence between each group, and given the paucity of lit-
erature exploring depression in ASC, identify robust
candidate measures used in the general population
which could be successfully adapted for adults with
ASC. From this synthesis of the available evidence, we
subsequently make recommendations for future
research aiming to effectively assess depression in ASC.
Review Methods: Stage 1
The protocol for this review is registered within the
International Register of Systematic Reviews (Registra-
tion number: CRD42016035220), and can be accessed
online (http://www.crd.york.ac.uk/PROSPERO/prospero.
asp). This systematic review follows the guidelines for
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses standards.
Search Strategy
The following electronic bibliographic databases were
searched: Medline, PsychINFO and Web of Knowledge.
The Cochrane library was also searched to confirm that
no other systematic reviews of the current study topic
existed. There were two searches carried out in stage
one for depression measures used in; (a) adults with
ASC, without co-morbid intellectual disability; and (b)
general population adults, without any co-morbid con-
ditions. The terms for each search strategy are included
in Table 1. The searches were restricted to peer-
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reviewed articles published in the English language,
between 1992 and June 2016—when the last searches
were run. The current study focused on literature per-
taining to ASC without co-morbid intellectual disabil-
ity, which is frequently referred to as Asperger
syndrome (AS). AS was first included as a separate diag-
nosis in the WHO International Classification of Dis-
eases (ICD-10) in 1992, so we focused on studies
published after this date, when we expected reference
to AS to be more consistent in the literature.
Selection Criteria
COSMIN recommends focusing searches on a well-
defined group and outcome. Therefore, studies had to
focus on a tool to specifically assess depression (as
opposed to a subscale contained within a larger mea-
sure, e.g., structured clinical interview [SCID]), clinically
defined as in the ICD-10, and diagnostic and statistical
manual of mental disorders (DSM-V). We searched for
studies utilizing tools to assess either the prevalence of
depression (epidemiological/population studies), or to
assess outcomes (treatment/intervention and longitudi-
nal/cohort studies). To be included, studies had to focus
on adults aged 18 years and over, without co-morbid
intellectual disability. Where the age range was partly
outside this, studies were included if 50% or more of
the total sample studied was over 18 years old, and the
mean age of the sample was 18 years or above. This
ensured that the tools were likely to be appropriate for
adults. We excluded articles using tools which had
been adapted specifically for a population other than
ASC or general population (e.g., for older adults, a par-
ticular gender, or a specific culture). In search one,
which included studies focusing on the adult general
(nonclinical) population, studies were included if data
from the general population were presented separately,
and the sample consisted of 50% or more participants
from the general population. Any studies including an
ASC comparison group were excluded at this stage and
considered for inclusion in search two, which included
studies focusing on adults with ASC without co-morbid
intellectual disability. If a study included participants
with a range of different diagnoses, the study was
included if ASC data were presented separately, and if
50% or more participants had ASC. In searches where
studies had used more than one version of a tool, we
included studies using the most up to date version
(e.g., the BDI-II).
One reviewer (L.B.) screened the titles and abstracts
of articles for inclusion, and where there was any doubt
on whether an article should be carried over to the full
text sift, it was included. L.B. then conducted the full
text sift of articles, with any ambiguous papers dis-
cussed with S.C., E.B., and J.R. to reach consensus. All
references of included articles were also searched for
additional articles to include.
Data Extraction
Data extraction was performed by L.B., and 20% of
articles independently checked by S.C. A data extrac-
tion form was adapted from a form used in similar
research previously [Wigham & McConachie, 2014].
Data pertaining to: participant characteristics, tools
used, domains captured and study type were recorded.
Results: Stage 1
ASC
The search for studies using tools to assess depression
in adults with ASC, without co-morbid intellectual dis-
ability, identified 543 articles which were screened, and
12 of these were retained for analysis (Fig. 1). Seven of
Table 1. Stage 1 Review Search Terms
1. (ASC or ASD or Asperg* or Autis* or high functioning or pervasive developmental disorder* or PDD or HFA)
2. (general population or population sample or community sample or national* survey or household* survey or nonreferred or nonclinical or popula-
tion screen*)
3. (adult*)
4. (assess* or tool or treatment outcome or measure* or scale or quotient or inventory or instrument)
5. (depress* or low mood or affective disorder or mood disorder)
6. randomised controlled trial or randomized controlled trial
7. random*
8. comparative stud*
9. prospective stud*
10. intervention
11. treatment effectiveness evaluation or treatment response or treatment study
12. epidemiolog*
13. prevalence
14. (General Population Search) (6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) and (2 and 3 and 4 and 5)
15. (ASC Search) (6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) and 1 and 3 and 4 and 5
16. limit 14 and 15 to English Language; 1992—current; age 18 years 1
INSAR Cassidy et al./Measurement Properties of Depression Tools 3
these studies were cross-sectional studies characterizing
mental health in those with ASC, including between 27
and 255 participants with ASC. Five of these studies
used tools to assess depression after a treatment trial,
including one (in a single case study of CBT) to 49 par-
ticipants. Taken together, the evidence shows a small
number of cross sectional and treatment outcome stud-
ies which have used tools to assess depression which
have some evidence of validity (but not in the sample
studied). It is also important to note that none of the
tools utilized in these studies had been developed or
validated for people with ASC.
Four different tools were used to assess depression in
the studies (Table 2). Three of these had also been used
in the general population (BDI-II, HRSD, PHQ-9), but
one had not been identified in the general population
search: the Montgomery Asberg Depression Rating Scale
(MADRS). Therefore, this measure was also considered
further in stage 2.
General Population
The search for studies using depression tools in general
population adults without co-morbid conditions identi-
fied 2,147 articles which were screened, 64 of which
were retained for analysis (Fig. 1). Most of the included
studies reported results from large cross-sectional or
longitudinal studies of the population, including tools
measuring the prevalence of depression, and/or change
in depression in response to treatment programs. The
sample size of the included studies ranged from 10 to
133,113. Taken together the evidence shows a number
of large scale population studies which have used tools,
with evidence of validity, to assess depression in the
general population without co-morbid conditions.
Eight different tools were used to assess depression in
the studies (Table 2). Self-report questionnaires
included: The Beck Depression Inventory, second edi-
tion [BDI-II, Beck, Steer, & Brown, 1996]; The Centre
Figure 1. Results of search one.
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for Epidemiological Studies Depression Scale [CESD,
Radloff, 1977]; The Human Population Laboratory
Depression Scale [HPL; Kaplan, Roberts, Camacho, &
Coyne, 1987]; the Major Depression Inventory [MDI;
Bech, 1997]; the patient health questionnaire, 2 and 9
item versions [PHQ-2/9; Kroenke & Spitzer, 2002]; the
Short Depression-Happiness Scale [SDHS; Joseph, Linley,
Harwood, Lewis, & McCollam, 2004]; and the Zung Self
Rating Depression Scale [ZDS; Zung, 1965]. A clinician
administered interview, the Hamilton Rating Scale for
Depression [HRSD; Hamilton, 1960] was also identified.
Three of these tools (HPL; MDI; SDHS) had each only
been used in one study. Therefore, these tools were not
considered further, as we were interested in tools which
had been used frequently with evidence of validity (i.e.,
by reference to a previous validation study). The CESD
has been revised to better map depression according to
DSM-V criteria [Eaton et al., 2004], but the up-dated
version was not identified in the initial searches (likely
due to inclusion of suicidality items in the more recent
version). Hence, we searched for studies which assessed
the measurement properties of the CESD-R, rather than
the previous version of the tool, given that the revised
version will need to be used in future research studies.
Hence, five tools (BDI-II, CESD-R, PHQ-9, ZDS, and
HRSD) were considered further in stage 2 (Table 1).
Summary
Six tools which had been used frequently (at least
twice) with evidence of validity in adults from the gen-
eral or ASC populations were identified from the
searches and were considered further. In comparison to
the general population, there were relatively few studies
which utilized validated tools to assess depression in
adults with ASC (12 vs. 64), and none which used a
tool developed or validated specifically for adults with
ASC (Table 1).
Review Methods: Stage 2
The second stage of the review searched for evidence of
the measurement properties of the tools identified in
stage 1. To do this, a comprehensive search was carried
out using a methodological filter in PubMed, designed
to search for studies assessing the measurement proper-
ties of health outcome assessment tools [Terwee et al.,
2009]. As in stage 1, we focused on studies which had
explored the measurement properties of the tools in: (a)
adults with ASC, without co-morbid intellectual disabil-
ity; and (b) general population adults, without co-
morbid conditions. In the case of general population
adults, without co-morbid conditions, again we
excluded articles which explored the measurement
properties of measures in nonrepresentative samples,
such as patients, college students, older adults or other
subgroups (e.g., single gender, LGBT, army veterans).
This was to focus on evidence for the measurement
properties of tools used in representative general popu-
lation samples, as opposed to nonrepresentative sub-
groups of the population.
Data Extraction Method
Once articles were identified from the search, the meth-
odological quality of each article was assessed using the
COSMIN checklist (Consensus based Standards for the
selection of health based measurement Instruments)
[Mokkink et al., 2012]. COSMIN rates the evidence in
support of nine measurement properties on a 4-point
scale (from excellent to poor): internal consistency, reli-
ability, measurement error, content validity, structural
validity, hypothesis testing, criterion validity, respon-
siveness to change, and cross-cultural validity. COSMIN
implements a ‘worst score counts’ method, by which an
overall rating is assigned to each measurement property
based on the lowest score provided. For example, if a
study is rated excellent on all criteria related to internal
consistency (e.g., Cohen’s Kappa was calculated, an ade-
quate sample size was utilized etc.), but the study failed
to check the uni-dimensionality of the scale, then this
study would still be rated as ‘poor’ overall [Mokkink
et al., 2010]. The checklists were completed by SC, with
20% of the articles rated by SW, who was trained and
experienced in using COSMIN. Percentage agreement
between SC and SW was 72%, similar to previous stud-
ies [e.g., Wigham & McConachie, 2014]. Disagreements
were resolved with discussion and these agreed ratings
were utilized in the subsequent evidence synthesis.
Evidence Synthesis
The quality of the evidence in support of each measure-
ment property needs to be considered in the context of
the studies’ findings to gauge the amount of evidence
available for or against each measurement property.
First, the quantitative findings from each study are
given a rating of positive (in support of the property),
indeterminate (not possible to deduce whether the evi-
dence is for or against the property), or negative (evi-
dence against the property). For example, criterion
validity is considered positive when the study supplies
convincing evidence that the criterion used is indeed a
gold standard, and the correlation between the out-
come measure and the gold standard criterion is greater
than 0.7 [De Vet, Terwee, Mokkink, & Knol, 2011]. Sub-
sequently, the quality of the evidence is considered in
the context of the studies’ quantitative findings. Strong
evidence (111/22) is defined as one methodologically
excellent or several good studies which find consistent
evidence for or against a measurement property;
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moderate evidence (11/2) is defined as one methodo-
logically good or several fair studies which find consis-
tent evidence for or against a measurement property;
limited evidence (1/2) is defined as one methodological
fair study finding evidence for or against a measure-
ment property; conflicting evidence (1/2) is where the
evidence for or against a measurement property is not
consistent between studies; and indeterminate evidence
(?), is where there are only studies of poor methodologi-
cal quality available for a measurement property [Mok-
kink et al., 2012].
Results: Stage 2
Autism Spectrum Conditions
The PubMed search for studies assessing the measure-
ment properties of depression tools used in adults with
ASC, without co-morbid intellectual disability, identi-
fied 17 articles which were screened, one of which was
retained for analysis (Fig. 2). This study assessed the
measurement properties of the BDI-II in adults with
ASC (Table 3). There was indeterminate evidence for
internal consistency, as alphas were not calculated for
each subscale, and the uni-dimensionality of the instru-
ment was not checked in the current sample. However,
there was a high Cronbach’s alpha (.87) for the whole
scale. There was weak evidence in support of hypothesis
testing, as hypotheses were not formulated, but it was
possible to deduce what was expected, and adequate
correlations were reported with other measures of simi-
lar constructs (r> .63). There was weak evidence for cri-
terion validity, as it was not clear how missing items
were handled, despite acceptable correlations with clini-
cal diagnosis of depression (r5 .8).
General Population
The PubMed search for studies assessing the measure-
ment properties of depression tools used in general popu-
lation adults, without co-morbid conditions, identified
390 articles which were screened, 14 of which were
Figure 2. Results of search two.
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retained for analysis (Fig. 2). Table 3 shows the character-
istics of the study populations included in the analysis.
The methodological quality of the included studies is
presented in Table 4. None of the studies had explored
measurement error or responsiveness to change—there-
fore these properties are not included in the table. The
collated evidence pertaining to the measurement prop-
erties for each tool is presented in Table 5. Many of the
articles reported data on differences in scores and nor-
mative data, which are important for interpretability
[De Vet et al., 2011]. However, no studies reported min-
imal important change or floor or ceiling effects.
HDRS. No articles assessing the measurement proper-
ties of the HRDS in a general population sample
without co-morbid conditions were identified from the
search.
BDI-II. Four studies were found to assess a range of
measurement properties of the BDI-II in general popula-
tion adults, without co-morbid conditions. There was
weak evidence in support of internal consistency—
many studies did not calculate Cronbach’s alpha for
each sub scale separately. However, all studies showed
support for the internal consistency of the BDI-II total
score with acceptable alphas above (.7). There was weak
evidence in support of test-retest reliability with one
fair study (as it was unclear how missing items were
handled), with a high alpha (.89). There was strong evi-
dence for content validity in one methodologically
Table 4. Methodological Quality of Studies Included in Search Two Evidence Synthesis
Tool Article
Internal
Consistency Reliability
Content
Validity
Structural
Validity
Hypothesis
Testing
Cross
cultural
validity
Criterion
Validity Interpretability
BDI-II Gotham et al. [2015] poor fair fair
BDI-II Abubakar et al. [2016] fair excellent fair fair poor Y
BDI-II Kjærgaard et al.
[2014]
poor fair good Y
BDI-II Gomes-Oliveira,
Gorenstein, Neto,
Andrade, and Wang
[2012]
poor fair poor fair fair Y
BDI-II Segal et al. [2008] poor fair fair Y
PHQ-9 Chung et al. [2015] fair -
PHQ-9 Kiely and Butterworth
[2015]
fair Y
PHQ-9 Wang et al. [2014] fair fair fair fair fair Y
PHQ-9 Kocalevent et al.
[2013]
fair fair fair Y
PHQ-9 Yu et al. [2012] fair fair fair fair Y
PHQ-9 Martin et al. [2006] Good Y
ZDS Yamazaki et al. [2005] fair -
ZDS Chida et al. [2004] excellent Y
CESD-R Van Dam and Earley-
wine [2011]
excellent excellent good Y
MADRS Schulte-van maaren
et al. [2013]
poor good Y
Table 5. Quality of the Evidence of Each Tool from Search 2
Measure
Group Measurement Properties Interpretability
ASC GP
Internal
Consistency Reliability
Content
Validity
Structural
Validity
Hypothesis
Testing
Criterion
Validity
Cross-cultural
validity
Differences in
scores between
groups
BDI-II X ? 1 1 Y
X 1 1 111* 11 11 11 1 Y
PHQ-9 X 11 11 11 11 11 Y
ZDS X 111 1 Y
CESD-R X 111 111 11 Y
MADRS X ? 11 Y
*Content validity assessed in a translated version only.
? denotes unable to rate quality of evidence due to only evidence of poor quality being available.
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excellent study of the BDI-II in a non-English speaking
Kenyan sample. There was moderate evidence in sup-
port of structural validity from two studies. Both studies
showed fair evidence for a single factor solution. Evi-
dence for hypothesis testing was moderate—the BDI-II
showed acceptable correlations with other depression
measures (r> .57). There was weak evidence for cross-
cultural validity as there were weaknesses in the quality
of the translations (only one forward/backward transla-
tion), or failure to pre-test the items in a sample for
interpretability and cultural relevance. There was mod-
erate evidence for criterion validity. The BDI-II showed
adequate sensitivity (>.7) and specificity (>.8) in deter-
mining Major Depressive Episode with clinician ratings
used as the criterion.
PHQ-9. Six studies were found which explored a
range of measurement properties of the PHQ-9 in gen-
eral population adults. There was moderate evidence in
support of internal consistency with adequate Cron-
bach’s alphas (>.7) for the uni-dimensional measure
(confirmed using IRT methods and factor analytic
methods). There was moderate evidence in support of
test-retest reliability with correlations >.7. There was
moderate evidence for structural validity showing con-
sistent evidence for a one factor solution (using factor
analysis). There was moderate evidence for hypothesis
testing; the PHQ-9 correlated strongly with other mea-
sures of similar constructs (e.g., the BDI), and support
was found for consistent factor structure across time
points and sub groups. There was moderate evidence
for criterion validity, with acceptable sensitivity and
specificity (>.79) in detecting clinical diagnosis of
depressive disorder.
ZDS. Two studies were found which explored the
measurement properties of the ZDS. There was strong
evidence in support of structural validity with a 2-factor
solution. There was weak evidence in support of
hypothesis testing, showing significant correlation with
other measures of similar constructs (r> .61).
CESD-R. The CESD was recently updated with the
CESD-R to better map onto DSM criteria, so we focused
the search on the updated version, as this version will
likely be used in future research and clinical practice.
Only one study was found which explored the measure-
ment properties of the CESD-R in general population
adults without co-morbid conditions. Evidence in sup-
port of internal consistency was strong with one study
rated as excellent methodological quality. Evidence in
support of structural validity was strong with the study
showing evidence for a single factor solution. Evidence
in support of hypothesis testing was moderate, with the
study showing acceptable correlations with other mea-
sures of similar constructs (r> .58).
MADRS. One study was found which explored the
measurement properties of the MADRS in general
population adults. Evidence for internal consistency
was indeterminate with one available study rated as
poor, as the uni-dimensionality of the scale was not
checked. Evidence for criterion validity was moderate
with evidence for high sensitivity/specificity (>.95) for
clinical diagnosis of depression.
Discussion
Although depression is reported to be highly co-morbid
with ASC, prior to this review it was unknown whether
any robust validated tools exist with which to effec-
tively assess depression in adults with ASC. Results
reveal a paucity of research with adults with ASC, with-
out co-morbid intellectual disability, that has used a
validated tool to assess depression (12 studies), com-
pared to general population adults (64 studies).
Research has also used a smaller range of validated tools
to assess depression in those with ASC compared to the
general population. Only the BDI-II, PHQ-9 and MADRS
have been utilized among adults with ASC, whereas
research in the general population also frequently uses
the HDRS, ZDS, and CESD. Hence, despite depression
being a common difficulty among adults with ASC
[Ghaziuddin, 2005; Lever & Geurts, 2016], few studies
have used a validated depression measure, and no tool
is available that has been specifically developed for or
comprehensively validated with this group.
Only one study had explored the measurement prop-
erties of a validated depression tool—the BDI-II—in
adults with ASC [Gotham, Unruh, & Lord, 2015]. This
study provided weak evidence in support of hypothesis
testing and criterion validity. However, the study did
show an acceptable correlation between scores on the
BDI-II and clinical diagnosis of depression in those
with ASC. Hence, the BDI-II could have utility in
assessing depression in adults with ASC. However,
larger sample sizes are needed to establish the factor
structure, internal consistency, content validity and
reliability, to ensure that this measure is appropriate
for adults with ASC.
Fourteen studies had explored the measurement
properties of the BDI-II, PHQ-9, ZDS, CESD-R and
MADRS in general population adults, without co-
morbid conditions. However, none of these studies
assessed measurement error or responsiveness to
change. Across the studies, several common pitfalls
adversely affecting the methodological quality of the
studies were identified by the COSMIN checklist. For
example, many studies failed to make a number of clear
directional hypotheses, making it difficult to interpret
the quality of the evidence with respect to hypothesis
testing. Many studies failed to report how missing items
were dealt with, or check the uni-dimensionality of the
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scale before calculating internal consistency, which
should be performed separately for each subscale.
Despite these common pitfalls in the methodological
quality of studies assessing measurement properties of
depression measures in general population adults, the
BDI-II and PHQ-9 were identified as having robust evi-
dence for a range of measurement properties. In partic-
ular, both tools show acceptable levels of sensitivity
and specificity in detecting clinical diagnosis of depres-
sion in general population adult samples. This is
reflected in the research literature, as these measures
were found to be the most widely used in research from
search one. The PHQ-9 is also recommended in UK
NICE guidelines to screen for depression in clinical
services.
Results suggest that the BDI-II and PHQ-9 could have
potential to be adapted for adults with ASC, without
co-morbid intellectual disability. However, it remains
unclear whether traditional depression measures can
accurately detect depression in those with ASC to a sim-
ilar degree to those without ASC. For example, ques-
tions such as “Trouble falling or staying asleep, or
sleeping too much?” and “Moving or speaking so
slowly that other people could have noticed?”, overlap
with autism symptoms, and may be more likely to be
endorsed by those with ASC, even in the absence of
depression. In addition to symptomatic overlap
between ASC and depression symptoms, the cognitive
characteristics of ASC may also affect the usefulness of
existing tools to accurately detect depressive symptoms
in this group. For example, alexythymia (difficulty artic-
ulating one’s internal emotional experience) [Bird et al.,
2010], and literal interpretation of questions are com-
mon in those with ASC [Happe, 1995]. This could affect
ability to interpret and answer questions such as
“feeling down, depressed or hopeless”, and “I am sad
all the time”.
It is also possible that tools developed for the general
population are less sensitive in accurately identifying
depression in ASC, due to lack of autism-specific items
tailored to the unique presentation of depression in
these individuals. For example, loss of absorption in a
special interest [Clarke et al., 1989; Gillberg, 1985], agi-
tation, change in sleep pattern or social withdrawal
[Ghaziuddin, 2005], have all been identified as poten-
tially unique signs of depression in those with ASC.
Recent research has also shown associations between
sensory sensitivity and depressive symptoms in those
with ASC [Serafini et al., 2017; Bitsika, Sharpley, &
Mills, 2016]. Adults with ASC without co-morbid intel-
lectual disability also frequently report trying to camou-
flage their symptoms in an attempt to fit into social
situations, at great potential cost to their mental health
[Lai et al., 2016; Rynkiewicz et al., 2016]. These autism
specific traits and behaviors which may be associated
with depression in ASC populations have not yet been
considered in the context of depression measures. This
could mean that current tools may underestimate
depression in ASC, as they may not be sensitive to the
unique presentation of depression in this group. Future
research studies must consider adapting current tools,
including such autism specific items.
If it were the case that traditional depression mea-
sures are less able to detect depressive symptoms in
those with ASC, then we could predict differences in
the measurement properties of the instruments between
those with and without ASC. For example, traditional
depression measures may be less accurate at predicting
clinical diagnosis of depression in those with ASC, com-
pared to the general population. The factor structure of
these measures may not be the same in those with and
without ASC, as the aforementioned items may not be
measuring depression per se in those with ASC. Hence,
the internal consistency of the measures may also be
lower in ASC than general population samples. Con-
versely, we could predict that autism-specific measures
developed to capture the unique presentation of depres-
sion in ASC, would more strongly predict clinical diag-
nosis of depression in this group compared to
traditional measures designed for the general popula-
tion without ASC. We might also expect the internal
consistency of autism-specific measures to be higher
than tools designed for the general population, given
that the items should more easily identify symptoms
indicating depression in ASC, rather than ASC symp-
toms more generally. Future research studies should
explore the content validity of traditional depression
measures in those with ASC, to ensure that items are
interpreted appropriately, and relate to the construct to
be measured. Additional autism-specific questions cap-
turing the unique presentation of depression in those
with ASC, such as change in social withdrawal, sleep
patterns, sensory sensitivity, repetitive behaviors, and
loss of interest in a special interest should also be devel-
oped and their measurement properties explored in
ASC samples. Methods such as cognitive interviewing
could be useful in this regard.
This study has a number of strengths as well as limi-
tations. A key strength was using a rigorous method
(COSMIN) to systematically identify and evaluate rele-
vant studies. However, following this strict method
meant that many studies and some tools were excluded
from the analysis. For example, given that a key aim of
the current study was to identify robust candidate mea-
sures of depression for ASC adults, it was important to
focus on tools which include more specific and broader
conceptualizations of depression than is feasible in sub-
scales, which typically have a narrower definition of
depression and fewer items. This meant that broader
mental health assessment tools containing depression
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subscales such as the SCID were excluded. Subse-
quently, only one study using the BDI-II in an ASC
sample met criteria to be analyzed by the COSMIN
checklist. We also focused the search on studies which
included representative general population samples of
adults, without co-morbid conditions, and adults with
ASC, without co-morbid intellectual disability. This
ensured that we uncovered evidence relevant to well-
defined representative populations, comparable in
terms of age and intellectual functioning. As measures
may well operate differently among different popula-
tions and contexts, widening the search would likely
have produced more mixed results.
In such a new area of research (depression in ASC), it
could therefore be argued that adopting such rigorous
methods might have lead us to overlook other relevant
data which could indicate the usefulness of one tool
over another. However, our results are consistent with
other COSMIN reviews showing a paucity of research
pertaining to the measurement of outcomes in those
with ASC [e.g., Hanratty et al., 2015; Wigham & McCo-
nachie, 2014], despite a growing number of studies uti-
lizing these tools. This is problematic as many studies
which use a tool, do not typically provide adequate evi-
dence regarding the appropriateness or measurement
properties of that tool for use in a particular group
(e.g., reporting internal consistency without checking
the uni-dimensionality of the scale). This is the primary
reason for the development and increased use of COS-
MIN reviews—to provide clear recommendations for
future research and clinical practice on the basis of an
internationally standardized rating system. Using a
more inclusive approach without clear standardized
guidelines would therefore have impeded our ability to
make clear evidence based recommendations, or com-
pare our results to the growing number of similar COS-
MIN reviews in the area of outcome measurement in
ASC. Our findings are therefore an important call to
action for the research community, to improve the
amount and quality of future research regarding the
effective identification of depression in ASC, and devel-
opment of adapted assessment tools for this group.
Our search was also limited by the fact that we
focused only on studies in the English language, due to
lack of resources to allow translation of articles. Data
extraction was also conducted only in part by two inde-
pendent reviewers. Although COSMIN is a systematic
method of searching, compiling and rating evidence
with regard to the measurement properties of outcome
measures, there is a certain level of subjectivity in rat-
ing the quality of the evidence in each article. There-
fore, it must be acknowledged that another set of raters
may have found slightly different results. However,
there was good agreement between raters in the current
study (72%), which is similar to previous published
work using COSMIN [e.g., Wigham & McConachie,
2014].
In conclusion, this is the first systematic review to
use a robust tool (COSMIN) to rate the quality of the
evidence with regard to the assessment of depression in
adults with and without ASC. There is a lack of evi-
dence regarding the measurement properties of tools in
adults with ASC, and no tools which have been devel-
oped to assess depression in this group. The BDI-II and
PHQ-9 both have acceptable evidence in support of
their ability to accurately screen for clinical diagnosis of
depression in representative general population sam-
ples, without co-morbid conditions. ASC symptoms and
cognitive characteristics of this condition could affect
the usefulness of these traditional measures to accu-
rately detect depression in ASC populations. The mea-
surement properties of these tools must therefore be
explored further in ASC samples, and adaptations to
improve their properties considered and tested. Our
group are currently undertaking work to explore these
questions, in order to ultimately better characterize
depression and its measurement in adults with ASC.
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